[1] Bond JS, Beynon RJ. The astacin family of metalloendopeptidases [J]. Protein Science, 1995, 4:1247-1261. [2] Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation:molecular clones and activities[J]. Science, 1988, 242:1528-1534. [3]Shimell MJ, Ferguson EL, Childs SR, O'Connor MB. The Drosophila dorsal-ventral patterning gene tolloid is related to human bone morphogenetic protein 1[J]. Cell, 1991, 67:469-481. [4]Muir AM, Ren Y, Butz DH, et al. Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice[J]. Human Molecular Genetics, 2014, 23:3085-3101. [5]Asharani P, Keupp K, Semler O, et al. Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish[J]. The American Journal of Human Genetics, 2012, 90:661-674. [6]Martínez-Glez V, Valencia M, Caparrós-Martín JA, et al. Identifica-tion of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta[J]. Human muta-tion, 2012, 33:343-350. [7]Valencia M, Caparrós-Martin JA, Sirerol-Piquer MS, et al. Report of a newly indentified patient with mutations in BMP1 and underlying pathogenetic aspects[J]. American Journal of Medical Genetics Part A, 2014, 164:1143-1150. [8]Goodman SA, Albano R, Wardle FC, et al. BMP1-related metalloproteinases promote the development of ventral mesoderm in early Xenopus embryos[J]. Developmental Biology, 1998, 195:144-157. [9]Ge G, Greenspan DS. Developmental roles of the BMP1/TLD metalloproteinases[J]. Birth Defects Research Part C:Embryo Today:Reviews, 2006, 78:47-68. [10]Maéno M, Ying X, Wood TI, et al. Cloning and expression of cDNA encoding Xenopus laevis bone morphogenetic protein-1 during early embryonic development[J]. Gene, 1993, 134:257-261. [11]Hwang S, Partin JS, Lennarz WJ. Characterization of a homolog of human bone morphogenetic protein 1 in the embryo of the sea urchin, Strongylocentrotus purpuratus[J]. Development, 1994, 120:559-568. [12]Martí E. Expression of chick BMP-1/Tolloid during patterning of the neural tube and somites[J]. Mechanisms of Development, 2000, 91:415-419. [13]Fukagawa M, Suzuki N, Hogan BLM, Jones CM. Embryonic expression of mouse bone morphogenetic protein-1(BMP-1), which is related to the Drosophila dorsoventral gene tolloid and encodes a putative astacin metalloendopeptidase[J]. Developmental Biology, 1994, 163:175-183. [14]Canty-Laird E, Carré GA, Mandon-Pépin B, et al. First evidence of bone morphogenetic protein 1 expression and activity in sheep ovarian follicles[J]. Biology of Reproduction, 2010, 83:138-146. [15]Suzuki N, Labosky PA, Furuta Y, et al. Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid[J]. Development, 1996, 122:3587-3595. [16]Pappano WN, Steiglitz BM, Scott IC, et al. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases[J]. Molecular and Cellular Biology, 2003, 23:4428-4438. [17]Lin JJ, Maeda R, Ong RC, et al. XBMP-1B(Xtld), a Xenopus homolog of dorso-ventral polarity gene in Drosophila, modifies tissue phenotypes of ventral explants[J]. Development, Growth & Differentiation, 1997, 39:43-51. [18]Asawakarn S, Asawakarn T. Role of matrix metalloproteinases in animals[J]. The Thai Journal of Veterinary Medicine, 2013, 42:137-142. [19]Kim SH, Kang CW, Min KS, Yoon JT. Matrix metalloproteinases are important for follicular development in normal and miniature pigs[J]. Biotechnology Letters, 2014, 36:1187-1196. [20]Vos MC, van der Wurff AA, Last JT, et al. Immunohistochemical expression of MMP-14 and MMP-2, and MMP-2 activity during human ovarian follicular development[J]. Reproductive Biology and Endocrinology, 2014, 12:12. [21]Zhu G, Kang L, Wei Q, et al. Expression and regulation of MMP1, MMP3, and MMP9 in the chicken ovary in response to gonadotropins, sex hormones, and TGFB1[J]. Biology of Reproduction:Biolreprod, 2014, 113. 114249. [22]Matzuk MM, Li Q. How the oocyte influences follicular cell function and why[M]. Oogenesis:Springer, 2013:75-92. [23] Zhu G, Gui Y, Wang Q, et al. Bone morphogenetic proteins(BMP) 2, 4, 6 and 7 affect ovarian follicular development through regulation of follicle-stimulating hormone receptor(FSHR) and luteinizing hormone receptor(LHR) expression in goat granulosa cells[J]. Journal of Cell Biology and Genetics, 2013, 3:14-21. [24]Reddi AH. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development:noggin, chordin and DAN[J]. Arthritis Research, 2001, 3:1-5. [25]Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton[J]. Endocrine Reviews, 2003, 24:218-235. [26]Blader P, Rastegar S, Fischer N, Str?hle U. Cleavage of the BMP-4 antagonist chordin by zebrafish tolloid[J]. Science, 1997, 278:1937-1940. [27]Piccolo S, Agius E, Lu B, et al. Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity[J]. Cell, 1997, 91:407-416. [28]Jasuja R, Ge G, Voss NG, et al. Bone morphogenetic protein 1 prodomain specifically binds and regulates signaling by bone morphogenetic proteins 2 and 4[J]. Journal of Biological Chemistry, 2007, 282:9053-9062. [29] Wolfman NM, McPherron AC, Pappano WN, et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases [J]. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100:15842. [30]Ge G, Hopkins DR, Ho WB, Greenspan DS. GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells[J]. Molecular and Cellular Biology, 2005, 25:5846-5858. [31]Ta?k?n EA, Atabeko?lu CS, S?nmezer M. From primary follicle to ovulation[J]. Gazi Medical Journal, 2013, 24:142-146. [32]Ge G, Greenspan DS. BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein[J]. The Journal of Cell Biology, 2006, 175:111-120. [33]Tovar-Vidales T, Fitzgerald AM, Clark AF, Wordinger RJ. Transforming growth factor-β2 induces expression of biologically active bone morphogenetic protein-1 in human trabecular meshwork cells[J]. Investigative Ophthalmology & Visual Science, 2013, 54:4741-4748. [34]Kim B, Huang G, Ho WB, Greenspan DS. Bone morphogenetic protein-1 processes insulin-like growth factor-binding protein 3[J]. Journal of Biological Chemistry, 2011, 286:29014-29025. [35]Jamall H, Laird M, Hardy K, Franks S. Interaction of androgen with IGF signalling in preantral follicle development in the mouse ovary[J]. Endocrine Arstracts, 2014, 34:323. [36]Ge G, Fernández CA, Moses MA, Greenspan DS. Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor[J]. Proceedings of the National Academy of Sciences, 2007, 104:10010-10015. [37]Herrera I, Cisneros J, Maldonado M, et al. Matrix metalloproteinase(MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption[J]. Journal of Biological Chemistry, 2013, 288:25964-25975. [38]Xiao Q, Zhang F, Grassia G, et al. Matrix metalloproteinase-8 promotes vascular smooth muscle cell proliferation and neointima formation[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2014, 34:90-98. |